Literature DB >> 15152083

A novel and conserved pocket of human kappa-Fab fragments: design, synthesis, and verification of directed affinity ligands.

Enrique Carredano1, Herbert Baumann, Anna Grönberg, Nils Norrman, Gunnar Glad, Jinyu Zou, Oguz Ersoy, Elles Steensma, Andreas Axén.   

Abstract

Antibodies of type IgG may be divided into two classes, called lambda or kappa, depending on the type of light chain. We have identified a conserved pocket between the two domains CH1 and CL of human IgG kappa-Fab, which is not present in the lambda type. This pocket was used as a target docking site with the purpose of exploring the possibilities of designing affinity ligands that could function as such even after immobilization to gel. The idea of the design arose mainly from the results of the saturated transfer difference (STD-NMR) screening of 46 compounds identified by means of virtual docking of 60 K diverse compounds from the Available Chemicals Directory (ACD). Surface plasmon resonance (SPR) was used as an alternative method to monitor binding in solution. A total of 24 compounds belonging to a directed library were designed, synthesized, and screened in solution. They consist essentially of an amino acid condensed to a N,N'-methylated phenyl urea. STD-NMR results suggest that a small hydrophobic side chain in the condensed amino acid promotes binding, whereas a hydroxyl-group-containing side chain implies absence of STD-NMR signals. Three compounds of the directed library were immobilized and evaluated as chromatographic probes. In one case, using D-Pro as the condensed amino acid, columns packed with ligand-coupled Sepharose (Amersham Biosciences) retained two different monoclonal samples of kappa-Fab fragments with different variable regions, whereas a sample of monoclonal lambda-Fab fragments was not retained under similar chromatographic conditions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15152083      PMCID: PMC2279986          DOI: 10.1110/ps.04687404

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  22 in total

1.  Biosensor analysis of the interaction between immobilized human serum albumin and drug compounds for prediction of human serum albumin binding levels.

Authors:  A Frostell-Karlsson; A Remaeus; H Roos; K Andersson; P Borg; M Hämäläinen; R Karlsson
Journal:  J Med Chem       Date:  2000-05-18       Impact factor: 7.446

2.  Structure-based discovery of a new affinity ligand to pancreatic alpha-amylase.

Authors:  Maria Westerfors; Ulf Tedebark; Hans O Andersson; Sara Ohrman; Devapriya Choudhury; Oguz Ersoy; Yasuro Shinohara; Andreas Axén; Enrique Carredano; Herbert Baumann
Journal:  J Mol Recognit       Date:  2003 Nov-Dec       Impact factor: 2.137

3.  Improved methods for building protein models in electron density maps and the location of errors in these models.

Authors:  T A Jones; J Y Zou; S W Cowan; M Kjeldgaard
Journal:  Acta Crystallogr A       Date:  1991-03-01       Impact factor: 2.290

4.  Improving biosensor analysis.

Authors:  D G Myszka
Journal:  J Mol Recognit       Date:  1999 Sep-Oct       Impact factor: 2.137

Review 5.  Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-gamma-interferon antibody.

Authors:  Z C Fan; L Shan; B Z Goldsteen; L W Guddat; A Thakur; N F Landolfi; M S Co; M Vasquez; C Queen; P A Ramsland; A B Edmundson
Journal:  J Mol Recognit       Date:  1999 Jan-Feb       Impact factor: 2.137

6.  X-ray structures of the antigen-binding domains from three variants of humanized anti-p185HER2 antibody 4D5 and comparison with molecular modeling.

Authors:  C Eigenbrot; M Randal; L Presta; P Carter; A A Kossiakoff
Journal:  J Mol Biol       Date:  1993-02-20       Impact factor: 5.469

Review 7.  Bence-Jones proteins and light chains of immunoglobulins (first of two parts).

Authors:  A Solomon
Journal:  N Engl J Med       Date:  1976-01-01       Impact factor: 91.245

Review 8.  An overview of monoclonal antibody therapy of cancer.

Authors:  L M Weiner
Journal:  Semin Oncol       Date:  1999-08       Impact factor: 4.929

9.  Structure of a human monoclonal antibody Fab fragment against gp41 of human immunodeficiency virus type 1.

Authors:  X M He; F Rüker; E Casale; D C Carter
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

10.  Crystal structures of a rat anti-CD52 (CAMPATH-1) therapeutic antibody Fab fragment and its humanized counterpart.

Authors:  G M Cheetham; G Hale; H Waldmann; A C Bloomer
Journal:  J Mol Biol       Date:  1998-11-20       Impact factor: 5.469

View more
  1 in total

1.  A comprehensive analysis of novel disulfide bond introduction site into the constant domain of human Fab.

Authors:  Hitomi Nakamura; Moeka Yoshikawa; Naoko Oda-Ueda; Tadashi Ueda; Takatoshi Ohkuri
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.